Literature DB >> 3282892

Drug treatment and prevention of malaria.

N J White1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3282892     DOI： 10.1007/bf01061409

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  73 in total

1.  Quinine by continuous intravenous drip in the treatment of acute falciparum malaria.

Authors:  J H STRAHAN
Journal:  Trans R Soc Trop Med Hyg       Date:  1948-03       Impact factor: 2.184

2.  Isolation, characterization and standardization of a major metabolite of amodiaquine by chromatographic and spectroscopic methods.

Authors:  F C Churchill; D L Mount; L C Patchen; A Björkman
Journal:  J Chromatogr       Date:  1986-04-25

3.  In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum.

Authors:  S Fu; A Björkman; B Wåhlin; D Ofori-Adjei; O Ericsson; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

4.  Megaloblastic anemia and pancytopenia due to Proguanil in patients with chronic renal failure.

Authors:  M Boots; M Phillips; J R Curtis
Journal:  Clin Nephrol       Date:  1982-08       Impact factor: 0.975

5.  Chloroquine excretion following malaria prophylaxis.

Authors:  L L Gustafsson; B Lindström; A Grahnén; G Alván
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

6.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.

Authors:  M Frisk-Holmberg; Y Bergqvist; E Termond; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  On the question of dose-dependent chloroquine elimination of a single oral dose.

Authors:  L L Gustafsson; L Rombo; G Alván; A Björkman; M Lind; O Walker
Journal:  Clin Pharmacol Ther       Date:  1983-09       Impact factor: 6.875

8.  Pharmacokinetics of chloroquine in renal insufficiency.

Authors:  L A Salako; O Walker; A O Iyun
Journal:  Afr J Med Med Sci       Date:  1984 Sep-Dec

9.  Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

10.  Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine.

Authors:  I F Cook; M Y Kish
Journal:  Med J Aust       Date:  1985-08-19       Impact factor: 7.738
View more
  24 in total

1.  Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria.

Authors:  E Pussard; J P Lepers; F Clavier; L Raharimalala; J Le Bras; M Frisk-Holmberg; Y Bergqvist; F Verdier
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria.

Authors:  F Verdier; E Pussard; F Clavier; J Le Bras; C Gaudebout
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 3.  Antimalarial pharmacokinetics and treatment regimens.

Authors:  N J White
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

4.  The effect of metoclopramide on mefloquine pharmacokinetics.

Authors:  K Na Bangchang; J Karbwang; D Bunnag; T Harinasuta; D J Back
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

5.  Divided-dose kinetics of mefloquine in man.

Authors:  G Franssen; B Rouveix; J Lebras; J Bauchet; F Verdier; C Michon; F Bricaire
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

6.  Quinine induces reversible high-tone hearing loss.

Authors:  R J Roche; K Silamut; S Pukrittayakamee; S Looareesuwan; P Molunto; S Boonamrung; N J White
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

7.  Quinine uptake by human polymorphonuclear neutrophils.

Authors:  J el Benna; C Pasquier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

8.  Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.

Authors:  B F del Pozo; F Pérez-Vizcaíno; E Villamor; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii.

Authors:  E Holfels; J McAuley; D Mack; W K Milhous; R McLeod
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 10.  CNS adverse events associated with antimalarial agents. Fact or fiction?

Authors:  P A Phillips-Howard; F O ter Kuile
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.